Furthermore, we showed that direct inhibition of ATM phosphorylation is able to reduce OXPHOS levels in oncogene-driven cancer cells and to enhance apoptosis in response to TK inhibitors, thus highlighting the possibility to use ATM inhibitors in combination therapy. This evidence concerns the gene TKT and cancer.